NCT05536440View on ClinicalTrials.gov

A Study to Learn About Study Medicine Called PF-07261271 in Healthy People

PHASE1CompletedINTERVENTIONAL
Enrollment

35

Participants

Timeline

Start Date

October 17, 2022

Primary Completion Date

February 29, 2024

Study Completion Date

February 29, 2024

Conditions
Healthy
Interventions
DRUG

PF-07261271

IV or SC

DRUG

Placebo

IV or SC

Trial Locations (4)

84124

ICON, Salt Lake City

92630

Orange County Research Center, Lake Forest

92780

Orange County Research Center, Tustin

07724

Clinilabs, Eatontown

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY